The tfdC I D I E I F I, and tfdD II C II E II F II gene modules of plasmid pJP4 of Ralstonia eutropha JMP134 encode complete sets of functional enzymes for the transformation of chlorocatechols into 3-oxoadipate, which are all expressed during growth on 2,4-dichlorophenoxyacetate (2,4-D). However, activity of tfd I -encoded enzymes was usually higher than that of tfd II -encoded enzymes, both in the wild-type strain grown on 2,4-D and in 3-chlorobenzoate-grown derivatives harboring only one tfd gene module. The tfdD II -encoded chloromuconate cycloisomerase exhibited special kinetic properties, with high activity against 3-chloromuconate and poor activity against 2-chloromuconate and unsubstituted muconate, thus explaining the different phenotypic behaviors of R. eutropha strains containing different tfd gene modules. The enzyme catalyzes the formation of an equilibrium between 2-chloromuconate and 5-chloro-and 2-chloromuconolactone and very inefficiently catalyzes dehalogenation to form trans-dienelactone as the major product, thus differing from all (chloro)muconate cycloisomerases described thus far.
butions of the different tfd-encoded enzymes to the complete metabolism of pathway intermediates have not yet been determined, nor has it been shown that all genes encode functional enzymes. Pérez-Pantoja et al. (34) , by evaluating the function of the tfdCDEF (tfdC I D I E I F I; module I) and tfdD II C II E II F II (module II) genes in R. eutropha JMP222 for growth on 3CB, have shown that both modules encode functional enzymes for chlorocatechol metabolism. Similarly, Laemmli et al. (22) reported that all genes carried by tfd module II code for functional enzymes. However, a low level of dienelactone (4-carboxymethylenebut-2-ene-4-olide) hydrolase activity and an even lower activity against 2-chloromuconate were observed in strains containing module II genes, whereas a very poor maleylacetate reductase activity was found in strains containing only module I (34) . Therefore, despite its high similarity to genes encoding functional maleylacetate reductases (19) , tfdF I has been said to encode a poor or nonfunctional enzyme. Moreover, attempts to purify maleylacetate reductase from R. eutropha JMP134 yielded a protein with an N-terminal sequence matching that of TfdF II (45) , indicating a critical role of TfdF II for growth of strain JMP134 on 2,4-D. In addition to TfdF I and TfdF II , yet another maleylacetate reductase was evident in strain JMP134 by the induction of such an activity during growth of pJP4-cured derivative JMP222 on 4-fluorobenzoate (43) . The possibility that the low maleylacetate reductase activity observed in strain JMP222 containing module I is due to recruitment of the chromosomally encoded gene cannot, therefore, be excluded. A chromosomally encoded dienelactone hydrolase, which converts trans-dienelactone much faster than cis-dienelactone, is also present in strain JMP222 (43) and probably is responsible for the poor activity observed in strain JMP222 containing module II with cisdienelactone (34) . Thus, the contributions of the different tfd gene modules to chloroaromatic degradation in strain JMP134
are not yet clear. Interestingly, interruption of tfdC I , -D I , or -E I by transposon mutagenesis resulted in mutants no longer capable of growing on 2,4-D (8) , suggesting that the products of these genes play a major role in the metabolism of this substrate. In contrast, interruption of tfdF I resulted in only a slight retardation of growth. The critical importance of the tfdD Iencoded chloromuconate cycloisomerase is supported by the fact that diverse attempts to purify chloromuconate cycloisomerase from strain JMP134 resulted in purification of only TfdD I (17, 21) . In the present investigation, the importance of the different tfd-encoded enzymes, chlorocatechol 1,2-dioxygenase, chloromuconate cycloisomerase, dienelactone hydrolase, and maleylacetate reductase, for growth of R. eutropha on chloroaromatics was characterized biochemically.
MATERIALS AND METHODS
Bacterial strains. The 2,4-D-degrading organism R. eutropha JMP134 was isolated by Don and Pemberton (7) . R. eutropha JMP222 is a derivative of strain JMP134, cured of plasmid pJP4. R. eutropha JMP222(pBBR1M-I) and R. eutropha JMP222(pBBR1M-II) are derivatives of strain JMP222 containing either module I (pBBR1M-I) or module II chlorocatechol genes as described recently (34) .
Culture conditions and preparation of cell extracts. Growth in liquid culture was performed in the mineral salts medium described by Dorn et al. (9) containing 50 mM phosphate buffer (pH 7.4). The medium was supplemented with a carbon source, usually at 2.5 or 5 mM. Cells were grown in fluted Erlenmeyer flasks, incubated at 30°C on a rotary shaker at 150 rpm. Growth was monitored spectrophotometrically. Harvested cells were resuspended in Tris-HCl buffer (100 mM, pH 7.5) supplemented with 2 mM MnCl 2 and disrupted with a French press (Aminco, Silver Spring, Md.). Cell debris was removed by centrifugation at 100,000 ϫ g for 1 h at 4°C.
Enzyme assays. Muconolactone isomerase (EC 5.3.3.4) was assayed as described by Prucha et al. (40) in 50 mM sodium phosphate (pH 7.5) with 0.1 mM (4S,5S/4R,5R)-5-chloro-3-methylmuconolactone as the substrate. Accumulation of 3-methyldienelactone was analyzed spectrophotometrically at 270 nm (ε 3-methyl-trans-dienelactone ϭ 15,200 M Ϫ1 cm Ϫ1 ). Catechol 1,2-dioxygenase (EC 1.13.11.1), chlorocatechol dioxygenase, muconate cycloisomerase (EC 5.5.1.1), chloromuconate cycloisomerase (EC 5.5.1.7), and dienelactone hydrolase (EC 3.1.1.45) were measured as previously described (10, 43, 44) with catechol, 3-chlorocatechol, muconate, 3-chloromuconate, or cis-dienelactone as the substrate. Substrate concentrations in the enzymatic tests were usually 0.05 mM, except for catechols and substituted catechols, which were added at initial concentrations of 0.2 mM. 3-Chloromuconate, as the substrate for chloromuconate cycloisomerase, was prepared in situ from 4-chlorocatechol by using TfdC II that was partially purified by anion-exchange chromatography and that was free of any interfering enzyme activity. Activity of partially purified chloromuconate cycloisomerases was determined in the presence of an excess of dienelactone hydrolase. Generally, TfdE I , partially purified by hydrophobic interaction chromatography and free of any interfering enzyme activity, was used. Maleylacetate reductase (EC 1.3.1.32) was measured as described by Seibert et al. (45) by using 0.05 mM maleylacetate freshly prepared by alkaline hydrolysis of cis-dienelactone or through transformation by TfdE I partially purified by hydrophobicinteraction chromatography. For determination of the kinetic properties of Tfd-D II , the formation of cis-dienelactone was recorded at 305 nm. A reaction coefficient of 5,300 M Ϫ1 cm Ϫ1 was calculated after complete transformation of 3-chloromuconate (20 to 50 M) into cis-dienelactone.
Specific activities are expressed as micromoles of substrate converted or product formed per minute per gram of protein at 25°C. Protein concentrations were determined by the Bradford procedure (2).
Chromatographic separation of enzyme activities. Cells were harvested during late-exponential growth, and the cell extract (usually containing between 8 and 20 mg of protein per ml) was applied directly to a MonoQ HR5/5 column (Amersham Pharmacia Biotech) or mixed with an equal volume of 2 M (NH 4 ) 2 SO 4 and, after centrifugation, applied to a phenyl-Superose HR5/5 column (Amersham Biosciences, Freiburg, Germany). At least three independent experiments were performed for each type of growth condition to verify the reproducibility of the method. Elution of the respective activities was highly reproducible and varied between independent experiments by only Ϯ1 fraction, which corresponds to differences of 0.01 M NaCl or 0.02 M (NH 4 ) 2 SO 4 . Proteins were eluted from the MonoQ HR5/5 column by a linear gradient of NaCl (0 to 0.5 M) in Tris-HCl (50 mM, pH 7.5, supplemented with 2 mM MnCl 2 ) in a total volume of 25 ml or by a stepwise gradient of 0 to 0.14 M over 2 ml, 0.14 to 0.29 M over 17 ml, and 0.25 to 0.5 M over 6 ml. Proteins were eluted from the phenyl-Superose HR5/5 column by a linear gradient of (NH 4 ) 2 SO 4 (1 to 0 M) in Tris-HCl (50 mM, pH 7.5, supplemented with 2 mM MnCl 2 ) over 25 ml or by a stepwise gradient of 1 to 0.8 M over 2 ml, 0.8 to 0.5 M over 8 ml, 0.5 to 0.3 M over 2 ml, 0.3 to 0.2 M over 6 ml, and 0.2 to 0 M over 10 ml. For chromatographic separation of maleylacetate reductases, proteins were eluted from the MonoQ HR5/5 column by the gradients described above, with Tris-HCl buffer exchanged for phosphate buffer. The flow rate was always 1 ml/min, and the fraction volume was 0.5 ml. Partial purification of TfdD II was achieved by successive separation using hydrophobic interaction and gel filtration. The two fractions from the phenyl-Superose HR5/5 chromatography containing the most TfdD II activity were pooled, concentrated by ultrafiltration to a final volume of 0.5 ml, applied to a Superose 12 column (HR10/30) (Amersham Biosciences), and eluted with 50 mM Tris-HCl, pH 7.5, at a flow rate of 0.3 ml/min (fraction volume, 0.5 ml). Similarly, fractions from MonoQ HR5/5 chromatography containing TfdFI activity were pooled, concentrated, and subjected to gel filtration.
Electrophoretic methods. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) was performed on a Bio-Rad Miniprotein II essentially as described by Laemmli (23 For two-dimensional gel electrophoresis, a 250-l aliquot of a TfdF I -containing fraction obtained by anion-exchange chromatography was precipitated with 10% trichloroacetic acid, and then the precipitate was washed with ice-cold acetone. The protein was dissolved in 300 l of reswelling solution containing 7.4 M urea, 2 M thiourea, 4% CHAPS (3-[{3-cholamidopropyl}dimethylammonio]-1-propanesulfonate), 20 mM Tris base, 30 mM dithiothreitol (DTT), one-half tablet of protease inhibitor (MiniComplete; Roche Applied Biosciences, Mannheim, Germany), 5% IPG buffer, pH 4 to 7 (Amersham Biosciences) and applied to isoelectric focusing (IEF) ReadyStrips (Bio-Rad). After 100 kV ⅐ h focusing time in the first dimension (IEF), the gel strip was equilibrated for the second dimension (SDS-PAGE) twice for 15 min by using 5 ml of equilibration solution consisting of 6 M urea, 30% glycerol, 2% SDS, 0.06 mM bromophenol blue, 50 mM Tris base, pH 8.8, 65 mM DTT, and 260 mM iodoacetamide. The strip was applied then to an SDS-10 to 15% PAGE gel (1.5 mm thick) and developed overnight in an IsoDALT chamber (Amersham Biosciences).
N-terminal amino acid sequencing. Proteins were electroblotted onto a polyvinylidene difluoride membrane, and the membrane was stained with Coomassie brilliant blue R250. N-terminal amino acid sequencing was performed with an Applied Biosystems model 494A Procise HT sequencer.
Analytical methods. High-performance liquid chromatography (HPLC) of low-molecular-weight compounds was performed with a Lichrospher SC 100 RP8 reverse-phase column (125 by 4.6 mm; Bishoff, Leonberg, Germany). Methanol-H 2 O containing 0.1% (vol/vol) H 2 PO 4 was used as the eluant at a flow rate of 1 ml/min. The column effluent was monitored simultaneously at 210, 260, and 270 nm by a diode array detector (Shimadzu). Typical retention volumes using 25% (vol/vol) methanol were 7.7 (2-chloro-cis,cis-muconate), 2.5 (2-chloromuconolactone), 1.1 (5-chloromuconolactone), 4.1 (cis-dienelactone), and 1.8 ml (trans-dienelactone); those using 40% (vol/vol) methanol were 2.1 (2-chlorocis,cis-muconate) and 1.4 ml (cis-dienelactone); those using 50% (vol/vol) methanol were 4.4 (3CB) and 0.7 ml (2-chloro-cis,cis-muconate). Kinetic measurements were recorded on an UV 2100 spectrophotometer (Shimadzu Corporation, Kyoto, Japan).
Transformation of 2-chloromuconate by chloromuconate cycloisomerase. Transformation of 2-chloromuconate was usually performed in 50 mM Tris-HCl, pH 8. The reaction mixtures contained 500 M 2-chloromuconate and 20 to 100 mU (as determined with 50 M 3-chloromuconate as the substrate) of chloromuconate cycloisomerase per ml. Substrate transformation was monitored by HPLC.
Chemicals. Chemicals were purchased from Sigma-Aldrich Chemie GmbH, Taufkirchen, Germany; Baker Chemikalien, Griesheim, Germany; and Merck AG, Darmstadt, Germany. 3-Chlorocatechol was obtained from Promochem, Wesel, Germany. 2-Chloro-cis,cis-muconate and (4R,5R/4S,5S)-5-chloro-3-methylmuconolactone were prepared as described by Pieper et al. (36, 38) . (4R,5S)-5-Chloromuconolactone and (4S)-2-chloromuconolactone were prepared as described by Prucha et al. (40) . cis-Dienelactone was a generous gift from Stefan Kaschabek and Walter Reineke (Bergische Universität-Gesamthochschule, Wuppertal, Germany).
RESULTS
Growth of R. eutropha JMP222 derivatives containing pBBR1M-I or pBBR1M-II on 3CB and expression of Tfd gene products. Differences in the growth of R. eutropha JMP222 derivatives harboring tfd module I or II on 3CB have been reported previously (34) . Accordingly, R. eutropha JMP222(pBBR1M-I) exhibited significantly higher growth rates (0.19/h) and higher growth yields (0.22 units of optical density at 546 nm (OD 546 )/mM 3CB) during growth on 3CB than did R. eutropha JMP222(pBBR1M-II) (0.06/h and 0.13 OD 546 units/mM 3CB), as indicated by the turbidity of the culture obtained after complete transformation of the 3CB growth substrate (Fig. 2) . The observed differences in growth yield seem to be due to the significantly different amounts of intermediates produced during growth of the two strains. Thus, whereas R. eutropha JMP222(pBBR1M-I) accumulated 15% Ϯ 5% of added 3CB as 2-chloromuconate, more than 50% of added 3CB appeared as 2-chloromuconate in the culture supernatant during growth of R. eutropha JMP222(pBBR1M-II).
Whereas 2-chloromuconate was the only intermediate excreted during the growth of R. eutropha JMP222(pBBR1M-I), R. eutropha JMP222(pBBR1M-II) also excreted minute amounts of cis-dienelactone, corresponding to 2% of the substrate transformed. The accumulation of large amounts of 2-chloromuconate in strain JMP222 expressing module II, compared to the amounts accumulated in strain JMP222 expressing module I, can be explained by the recently reported very low activity of TfdD II chloromuconate cycloisomerase with this substrate (34) . Accumulation of cis-dienelactone can be assumed to have been due to the observed low activity of TfdE II dienelactone hydrolase in R. eutropha JMP222(pBBR1M-II) (Table 1) .
Maleylacetate, produced by the activity of dienelactone hydrolase on cis-or trans-dienelactone, was never observed in the culture supernatants, indicating that maleylacetate reductase did not constitute a pathway bottleneck in R. eutropha JMP222(pBBR1M-II) or in R. eutropha JMP222(pBBR1M-I), despite the fact that only poor maleylacetate reductase activities have been recently reported to be induced during growth of strain JMP222 expressing tfd module I (34). This discrepancy can be explained by the fact that the former enzyme activity measurements were performed with maleylacetate produced in situ by cell extracts. However, by using maleylacetate freshly prepared from cis-dienelactone by alkaline hydrolysis or purified dienelactone hydrolase and by measuring the enzymatic activity immediately after the preparation of a cell extract containing at least 5 mg of protein per ml, it was possible to reproducibly detect significant maleylacetate reductase activities in R. eutropha JMP222(pBBR1M-I) ( Table 1 ). All other enzyme activities were as previously reported (Table  1) (34) .
Levels of Tfd activity during growth of R. eutropha JMP134 on chloroaromatics. Due to the fact that all four enzymes involved in the chlorocatechol degradation of tfd modules I and II were obviously active and based on detection of the respective mRNAs, which showed that both gene modules were expressed during growth on 2,4-D (22, 24) , the importance of each gene module for the degradation of chloroaromatics in wild-type strain R. eutropha JMP134(pJP4) was investigated. Chromatographic methods were applied to partially purify and separate the respective isoenzymes from cell extracts without significant loss of activity. Strains R. eutropha JMP222(pBBR1M-I) and R. eutropha JMP222(pBBR1M-II) were used for the establishment of an optimized purification scheme.
Anion-exchange chromatography of cell extracts of 3CB-grown R. eutropha JMP222(pBBR1M-I) or JMP(pBBR1M-II) resulted in high recoveries of TfdC I (60% Ϯ 10% of applied activity), TfdC II (80% Ϯ 10%), TfdD I (70% Ϯ 10%), TfdD II (60% Ϯ 10%), TfdE I (90% Ϯ 10%), and TfdE II (90% Ϯ 10%) activity (Fig. 3A and B) , although only low activities of maleylacetate reductase (activity of TfdF I eluting at 0.21 Ϯ 0.02 M NaCl was usually lower than 5% of the applied activity, and activity of TfdF II eluting at 0.16 Ϯ 0.01 M NaCl was usually lower than 10%) could be recovered. However, TfdC I (eluting at 0.29 M NaCl) showed a distinctly different retention behavior than did TfdC II (eluting at 0.19 M NaCl). TfdD I and TfdD II also exhibited different properties (eluting at 0.43 and 0.17 M NaCl, respectively). TfdE I and TfdE II could not be separated by such a chromatographic method (eluting at 0.16 M NaCl). Optimization of the applied NaCl gradient did not result in a significant enhancement of separation.
Resolution of soluble enzymes by anion-exchange chromatography clearly indicated that two peaks of activity against catechol (Fig. 3B) were recovered from R. eutropha JMP222(pBBR1M-II). Thus, the high level of catechol 1,2-dioxygenase activity with catechol, compared to that with 3-chlorocatechol in 3CB-grown cells of strain JMP222(pBBR1M-II) (Table 1) , is due to the induction of the chromosomally encoded catechol 1,2-dioxygenase (eluting at 0.22 M NaCl) in addition to TfdC II . Whereas TfdC II exhibited similar activities against both catechol and 3-chlorocatechol, transformation of 3-chlorocatechol by fractions containing catechol 1,2-dioxygenase was negligible. A chromosomally encoded muconate cycloisomerase (exhibiting significant activity only with cis,cis-muconate and eluting at 0.22 M NaCl) was also induced under these conditions (Fig. 3B) . A similar induction of enzymes of the 3-oxoadipate pathway has previously 4-fluorobenzoate (43) , as the enzyme induced in strain JMP222(pBBR1M-II) exhibited similar activities against both cis-and trans-dienelactone (activity with trans-dienelactone was 60% of that with cis-dienelactone at substrate concentrations of 50 to 100 M). The chromosomally encoded enzyme, in contrast, has been shown to exhibit activity only against trans-dienelactone (43).
Hydrophobic interaction chromatography was observed to be superior to anion-exchange chromatography, allowing separation of the different chlorocatechol dioxygenases and chloromuconate cycloisomerases, as well as the dienelactone hydrolases ( Fig. 3D and E) . However, the yields (50% Ϯ 10% for TfdD I and TfdD II ; 60% Ϯ 10% for TfdE I , TfdE II , and TfdC II ; and 70% Ϯ 10% for TfdC I ) were usually slightly lower than those obtained by anion-exchange chromatography, and hydrophobic-interaction chromatography also failed to give highly active preparations of maleylacetate reductase. Although a reasonable maleylacetate reductase activity, corresponding to less than 20% of the applied activity (eluting at 0.16 M [NH 4 ] 2 SO 4 ), could be observed after hydrophobic-interaction chromatography of a cell extract of 3CB-grown strain JMP222(pBBR1M-II), only negligible activity (corresponding to less than 5% of the applied activity and eluting at 0.60 Ϯ 0.04 M [NH 4 ] 2 SO 4 ) could be recovered from a cell extract of strain JMP222(pBBR1M-I) grown on 3CB.
Neither TfdCI nor TfdE II interacted with the column material under the applied conditions (i.e., an initial ammonium sulfate concentration of 1 M; Fig. 3D and E) . Further increases in the initial ammonium sulfate concentration resulted in precipitation of dienelactone hydrolase activities. However, no catechol 1,2-dioxygenase activity against 3-chlorocatechol was observed in the initially eluting fractions during separation of the JMP222(pBBR1M-II)-derived extract. Furthermore, no activity against cis-dienelactone could be found in the respective fractions after separation of a JMP222(pBBR1M-I)-derived extract, indicating that the activities assigned to TfdC I or TfdE II were not due to chromatographic artifacts.
R. eutropha JMP134 was grown on 2,4-D, and, subsequently, the soluble proteins were separated by means of hydrophobicinteraction chromatography (Fig. 3F) . The activities of tfd Iencoded enzymes TfdC I , TfdD I , and TfdE I were approximately 40 to 70% of those induced during growth of strain JMP222(pBBR1M-I) on 3CB, and those of tfd II -encoded enzymes TfdC II , TfdD II , and TfdE II were approximately 25 to 50% of those induced during growth of strain JMP222(pBBR1M-II) on 3CB. As the yields of the respective isoenzymes after chromatographic separation were always similar, the comparison of total activities in the respective fractions indicates the actual importance of the respective enzymes for the degradation process. As shown in Fig. 3F , in 2,4-Dgrown cells of R. eutropha JMP134, the Tfd II -derived enzyme activities comprised 20% Ϯ 5% of the observed total activity against 3-chlorocatechol and 3-chloromuconate but only approximately 5% of the observed activity against cis-dienelactone.
Characterization of maleylacetate reductases induced during growth of R. eutropha JMP134 and derivatives on chloroaromatics. R. eutropha JMP222 is capable of growth on 4-fluorobenzoate, and induction of a chromosomally encoded maleylacetate reductase under these conditions has been reported (43) . Therefore, the possibility that the maleylacetate reductase activities observed during growth of strain JMP222(pBBR1M-I) or JMP222(pBBR1M-II) on 3CB (Table  1) are, at least partially, due to recruitment of this chromosomally encoded maleylacetate reductase cannot be excluded. Partial purification of this enzyme activity, which was usually induced at levels of 300 Ϯ 50 U/g of protein in 4-fluorobenzoate-grown cells of strain JMP222, showed that this enzyme, in contrast to the activities induced in strains JMP222(pBBR1M-I) and JMP222(pBBR1M-II), exhibits high stability. Approximately 50% of the applied activity could be recovered by hydrophobicinteraction chromatography; the activity eluted at 0.38 M ammonium sulfate (Fig. 3D, inset) . As no significant activity was observed in the respective fractions after separation of JMP222(pBBR1M-I)-or JMP222(pBBR1M-II)-derived cell extracts, it can be concluded that the chromosomally encoded maleylacetate reductase activity was not recruited in these strains for growth on 3CB. Similarly, as no significant activity was observed in the respective fractions after separation of a cell extract of 2,4-D-grown cells of strain JMP134 (Fig. 3F) , it seems that the chromosomally encoded maleylacetate reductase does not play a major role in the degradation of this substrate in the wild-type strain.
Approximately 90% of the applied maleylacetate reductase activity of 4-fluorobenzoate-grown cells of R. eutropha JMP222 was recovered by anion-exchange chromatography; the activity eluted at 0.2 M NaCl (Fig. 3A, inset) , a condition similar to those under which the activities of JMP222(pBBR1M-I) and JMP222(pBBR1M-II) eluted. However, the yields of the latter maleylacetate preparations were Ͻ5 and 10% Ϯ 5%, respectively, again indicating that the chromosomally encoded maleylacetate reductase plays no significant role during 3CB degradation by strain JMP222(pBBR1M-I) or JMP222(pBBR1M-II).
As neither hydrophobic-interaction chromatography nor anion-exchange chromatography resulted in sufficient resolution of the three maleylacetate reductase activities or in reasonable yields of TfdF II or, particularly, TfdF I , anion-exchange chromatography was applied and Tris-HCl buffer in the eluant was replaced by phosphate buffer. This simple change had a marked effect on the retention behavior of the chromosomally encoded maleylacetate reductase, as well as on the TfdE I enzyme, as their interactions with the column material were nearly abolished (Fig. 3C) . Moreover, the use of phosphate buffer dramatically increased the yield of TfdF I . In a typical separation run, after application of a cell extract of strain JMP222(pBBR1M-I) containing 15 mg of protein, the two most active fractions contained, together, 7,050 mU of TfdF I activity and 0.48 mg of protein (corresponding to a specific activity of 14,700 U/g of protein) in a complete volume of 1 ml. Further purification by gel filtration resulted in a significant loss of activity. Less than 10% of the applied activity was recovered, with specific activities of up to only 800 U/g of protein.
To further demonstrate that the maleylacetate reductase induced in 3CB-grown strain JMP222(pBBR1M-I) is identical to TfdF I , an aliquot of a highly active fraction obtained by anion-exchange chromatography, containing 240 g of protein, was subjected to two-dimensional gel electrophoresis and blotted onto a polyvinylidene difluoride membrane and a major protein spot corresponding to the estimated molecular mass of VOL. 184, 2002 tfd GENES OF RALSTONIA EUTROPHA 4059 the TfdF I subunit (37.9 kDa) was analyzed by N-terminal sequencing. The amino-terminal sequence was identified as MKKFTLDYLSPR; this sequence was identical to the sequence deduced from the tfdF I gene. Therefore, it can be assumed that the maleylacetate reductase activity present in 3CB-grown cells of strain JMP222(pBBR1M-I) is, in fact, due to expression of tfdF I . Thus, the use of anion-exchange chromatography with phosphate buffer has enabled the characterization of the expression of TfdF I , as well as of the different dienelactone hydrolases and catechol 1,2-dioxygenases, during growth of R. eutropha JMP134 and JMP222 derivatives.
2,4-D-grown cells of strain JMP134 induce significant levels of TfdF I , comprising roughly half of the total maleylacetate reductase activity. Calculations of the levels of TfdC I versus TfdC II and of TfdE I versus TfdE II in those cells confirmed the results obtained above by hydrophobic interaction chromatography, with 20% of the total chlorocatechol 1,2-dioxygenase activity due to TfdC II and 5% of the total dienelactone hydrolase activity due to TfdE II .
Characterization of chloromuconate cycloisomerase TfdD II. Compared to the previously described chloromuconate cycloisomerases from gram-negative microorganisms (21, 51) the chloromuconate cycloisomerase activity encoded by tfdD II exhibited very poor activity against 2-chloromuconate, possibly resembling chloromuconate cycloisomerase of Rhodococcus opacus 1CP (46) . Therefore, this enzyme activity was further characterized. TfdD II was partially purified from 3CB-grown cells of strain JMP222(pBBRM1-II) by anion-exchange chromatography and gel filtration. A total of 2.1 U (calculated for a substrate concentration of 50 M 3-chloromuconate) of chloromuconate cycloisomerase (specific activity of 185 U/g) was applied to a MonoQ column. The three most active fractions eluting from the column were pooled (1.8 U with a specific activity of 650 U/g) and subjected to gel filtration. A total of 0.8 U was recovered in four fractions, with specific activities as high as 3,800 U/g. Kinetics experiments were performed by quantification of cis-dienelactone formation at 305 nm, and a K m value of 190 Ϯ 15 M was calculated. For quantification of TfdD II in active fractions, aliquots were separated by PAGE (40 to 300 ng of protein per fraction) and stained with Sypro Ruby. A major band with a molecular mass of 41 Ϯ 1 kDa, which contained 30 to 60% of the total protein in the respective fractions, was observed. The N-terminal sequence of this protein (MLTEKAIADSPN) was identical to that expected for TfdD II . Thus, maximal transformation rates calculated during kinetics experiments could be related to the amount of TfdD II present. Taking into account the predicted subunit molecular mass of 36.9 kDa, a k cat value of 1,950 Ϯ 150 min Ϫ1 was calculated. By the photometric test (depletion in the presence of an excess of dienelactone hydrolase as measured at ϭ 260 nm), TfdD II exhibited significant activity only against 3-chloromuconate and poor activity against 2-chloro-substituted muconate, as well as against unsubstituted muconate. At a substrate concentration of 0.1 mM, the activity with muconate was only 0.4% Ϯ 0.1% of that with 3-chloromuconate and the activity with 2-chloromuconate was 0.8% Ϯ 0.2%.
This substrate spectrum significantly resembles that reported for chloromuconate cycloisomerase of Rhodococcus opacus (46) . This cycloisomerase differs from those of previously described gram-negative organisms in that it lacks the ability to convert 2-chloromuconolactone and to form transdienelactone from 2-chloromuconate. Thus, the kinetic properties of the TfdD II chloromuconate cycloisomerase were assessed by using the partially purified enzyme fractions described above. These fractions were free of any muconate cycloisomerase (capable of transforming 2-chloromuconolactone), muconolactone isomerase (capable of dehalogenating intermediate 5-chloromuconolactone), or dienelactone hydrolase activities. As shown in Fig. 4 , the predominant products formed from 2-chloromuconate were identified as 2-and 5-chloromuconolactone. The ratio between 2-chloromuconate, 5-chloromuconolactone, and 2-chloromuconolactone, after a short incubation period, was about 20:4:3, as previously reported for the equilibrium between those compounds after addition of muconate cycloisomerases (50) . Further incubation resulted in the formation of mainly trans-dienelactone and minor amounts of cis-dienelactone. A control incubation using partially purified muconate cycloisomerase resulted in the formation of a similar equilibrium between 2-chloromuconate and 5-and 2-chloromuconolactone. However, the rate of transdienelactone formation was negligible in those assays (less than 2 M h Ϫ1 in the presence of 100 mU of muconate cyc- loisomerase per ml, compared to 12 M h Ϫ1 in the presence of 100 mU of Tfd II per ml).
Incubation of TfdD II with 2-chloromuconolactone resulted in formation of the equilibrium between 2-chloromuconate and 2-and 5-chloromuconolactone described above, demonstrating that TfdD II , in contrast to the Rhodococcus enzyme, can transform 2-chloromuconolactone. Considerable levels of trans-dienelactone formation were visible only after significant accumulation of 5-chloromuconolactone.
D-grown cells of strain JMP134 (Table 1) . Expression of catechol and chlorocatechol operons usually requires LysR-type transcriptional activators and inducer muconate (catechol operons) or 2-chloromuconate (chlorocatechol operons) (28) . In strain JMP134, the tfdR gene product is responsible for expression of the tfd operons (25) and it is activated by chloromuconates (14) . It has been proposed that, even in the absence of tfdR, low-level expression of tfdCDEF occurs, implying a cross-activation by chromosomally encoded regulatory elements (14) . In P. putida it has been shown that CatR, the regulator of the catBC operon (for catechol degradation), interacts with the clcABD promoter region and, likewise, clcR, the regulator of the clcABD operon (for chlorocatechol degradation), was shown to interact with the catBC promoter region. CatR could even complement a ClcR Ϫ mutant P. putida strain harboring the clcABD operon for growth on 3CB (29, 33) . Moreover, it was recently demonstrated that the LysR-type regulator of the cbn operon of R. eutropha NH9 is activated by both muconate and 2-chloromuconate (30), implying the presence of significant cross talk among the homologous transcriptional activators. Consequently, it seems likely that the accumulated 2-chloromuconate may drive expression of the catechol pathway genes by acting on a putative catR-like element in the chromosomes of strains JMP134 and JMP222. However, induction was observed only in a subset of growth conditions or genetic backgrounds, specifically those that resulted in accumulation of a high level of 2-chloromuconate during growth. Thus, evidently, highly elevated levels of intracellular 2-chloromuconate are necessary to achieve expression of catechol catabolic genes. This agrees with observations of Cosper et al. (6) , who proposed that versions of Acinetobacter sp. strain ADP1 containing variants of the muconate cycloisomerase with reduced catalytic properties have increased intracellular levels of muconate available, which are responsible for the activation of LysR-type regulator CatM, which is, in turn, capable of activating the expression of genes encoding enzymes for benzoate degradation.
On one hand, the activation of the catechol pathway genes in R. eutropha can be regarded as a burden for the strain. However, an induction of this type can be proposed to have advantageous effects, as well, specifically for strains such as JMP222(pBBR1M-II). Catechol 1,2-dioxygenase and muconate cycloisomerase have some activity on chlorinated substrate analogues (21, 37 ) and thus to a certain extent can be responsible for transformation of pathway intermediates. 2-Chloro-and 3-chloromuconate will, thereby, be transformed into chloromuconolactones (50) and protoanemonin (1), respectively. Protoanemonin accumulation, when this compound is produced at low rates, can be prevented by dienelactone hydrolase (3), and muconolactone isomerase can support the dehalogenation of any 5-chloromuconolactone (39) formed during cycloisomerization of 2-chloromuconate by muconate cycloisomerase or TfdD II . Thus, it can be assumed that part of 3CB in strain JMP222(pBBR1M-II) is mineralized by a com- plex metabolic interplay between chromosome-and plasmidencoded enzymes.
